Lumida
/MEDS
⌘K
MEDS

MEDS

MEDS
$0.90USD+0.91%+0.01 today

MARKET CAP

2.9M

P/E (TTM)

0.1x

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$45
STATEMENT·Income statement
USD · GAAP
METRICFY 2020FY 2021FY 2022FY 2023TREND
Sales, Adj.$17.1M$9.9M$10.3M$1.4M
YoY %-42.2%+3.6%-86.7%
P / Sales
EV / Sales
Gross Profit, Adj.$5.7M$4.7M$5.5M$49,030
YoY %-16.8%+16.3%-99.1%
Margin %33.3%48.0%53.8%3.6%
EV / Gross Profit
EBITDA, Adj.$-1.8M$-2.9M$-1.2M$-2.1M
YoY %-60.7%+58.0%-71.6%
Margin %-10.4%-28.8%-11.7%-150.7%
EV / EBITDA
EBIT$-2.5M$-5.3M$-2.0M$-4.4M
YoY %-111.1%+61.4%-115.4%
Margin %-14.6%-53.5%-19.9%-322.4%
EV / EBIT
Net Income$-2.5M$-5.3M$-3.5M$-17.8M
YoY %-109.6%+34.7%-413.9%
Net Margin-14.8%-53.8%-33.9%-1308.3%
EPS (GAAP)-$0.33-$0.65-$6.13-$7.49
YoY %-97.0%-843.1%-22.2%